Gardner Lewis Asset Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Gardner Lewis Asset Management's LLY Position: Q2 2026 in Review
Gardner Lewis Asset Management reduced its Eli Lilly (LLY) stake by 5.2% in Q2 2026, selling an estimated $276K and leaving 4,878 shares worth $5.85M. The position accounts for 1.3% of the portfolio, ranked #24.
Gardner Lewis Asset Management first reported a position in LLY in Q4 2021 and has held it in 11 quarters since. 4,634 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Gardner Lewis Asset Management held 4,878 shares of Eli Lilly worth $5.85M as of Q2 2026.
- Gardner Lewis Asset Management sold 270 Eli Lilly shares in Q2 2026, an estimated $276K.
- Eli Lilly made up 1.3% of Gardner Lewis Asset Management's portfolio in Q2 2026, its #24 holding.
- Gardner Lewis Asset Management first reported a position in Eli Lilly in Q4 2021 and has held it in 11 quarters since.
- 4,634 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Gardner Lewis Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.